152 related articles for article (PubMed ID: 26867162)
1. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
[TBL] [Abstract][Full Text] [Related]
2. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
3. [Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction].
Lai FF; Niu F; Yang HZ; Zhou WQ; Chen XG
Yao Xue Xue Bao; 2014 Jun; 49(6):849-53. PubMed ID: 25212031
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
6. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
[TBL] [Abstract][Full Text] [Related]
7. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.
Lu H; Li Y; Shu M; Tang J; Huang Y; Zhou Y; Liang Y; Yan G
FEBS J; 2009 Dec; 276(24):7291-304. PubMed ID: 19912340
[TBL] [Abstract][Full Text] [Related]
9. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
Staab A; Loeffler J; Said HM; Diehlmann D; Katzer A; Beyer M; Fleischer M; Schwab F; Baier K; Einsele H; Flentje M; Vordermark D
BMC Cancer; 2007 Nov; 7():213. PubMed ID: 17999771
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
Law AY; Wong CK
Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
[TBL] [Abstract][Full Text] [Related]
11. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
12. Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
Goey AK; Chau CH; Sissung TM; Cook KM; Venzon DJ; Castro A; Ransom TR; Henrich CJ; McKee TC; McMahon JB; Grkovic T; Cadelis MM; Copp BR; Gustafson KR; Figg WD
J Nat Prod; 2016 May; 79(5):1267-75. PubMed ID: 27140429
[TBL] [Abstract][Full Text] [Related]
13. Increased NFAT5 expression stimulates transcription of Hsp70 in preeclamptic placentas.
Park JK; Kang TG; Kang MY; Park JE; Cho IA; Shin JK; Choi WJ; Lee SA; Choi WS; Kwon HM; Lee JH; Paik WY
Placenta; 2014 Feb; 35(2):109-16. PubMed ID: 24398013
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
15. MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI-1 gene.
Tong Q; Weaver MR; Kosmacek EA; O'Connor BP; Harmacek L; Venkataraman S; Oberley-Deegan RE
Free Radic Biol Med; 2016 May; 94():185-94. PubMed ID: 26944191
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.
Borsi E; Terragna C; Brioli A; Tacchetti P; Martello M; Cavo M
Transl Res; 2015 Jun; 165(6):641-50. PubMed ID: 25553605
[TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis.
Misra RM; Bajaj MS; Kale VP
PLoS One; 2012; 7(11):e50153. PubMed ID: 23185562
[TBL] [Abstract][Full Text] [Related]
18. NF-κB suppresses HIF-1α response by competing for P300 binding.
Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
[TBL] [Abstract][Full Text] [Related]
19. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
20. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.
Kung AL; Zabludoff SD; France DS; Freedman SJ; Tanner EA; Vieira A; Cornell-Kennon S; Lee J; Wang B; Wang J; Memmert K; Naegeli HU; Petersen F; Eck MJ; Bair KW; Wood AW; Livingston DM
Cancer Cell; 2004 Jul; 6(1):33-43. PubMed ID: 15261140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
